| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 32.76▲ | 32.77▲ | 32.83▲ | 31.94▲ | 30.81▲ |
| MA10 | 32.65▲ | 32.65▲ | 32.49▲ | 31.45▲ | 27.49▲ |
| MA20 | 32.67▲ | 32.36▲ | 31.99▲ | 30.31▲ | 24.61▲ |
| MA50 | 32.45▲ | 31.81▲ | 31.72▲ | 26.62▲ | 17.99▲ |
| MA100 | 32.00▲ | 31.62▲ | 30.92▲ | 23.69▲ | 16.07▲ |
| MA200 | 31.86▲ | 30.67▲ | 28.89▲ | 18.10▲ | 16.51▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.031▲ | 0.048▲ | 0.111▲ | 0.064▲ | 0.685▲ |
| RSI | 69.904▲ | 66.055▲ | 68.465▲ | 69.417▲ | 76.308▲ |
| STOCH | 63.889 | 78.503 | 85.712▲ | 80.431▲ | 90.829▲ |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | 0.350▲ | 0.155▲ |
| CCI | 319.078▲ | 104.795▲ | 138.341▲ | 113.166▲ | 143.605▲ |
|
Monday, November 10, 2025 01:11 PM
Released positive Phase 1b interim results for long-acting helicase-primase inhibitor candidate ABI-5366 showing significant reductions in ...
|
|
Friday, November 07, 2025 05:17 AM
Phase 1b data demonstrating favorable safety and tolerability profile and potent reductions in viral nucleic acids highlighted in late-breaking poster presentation – SOUTH SAN FRANCISCO, Calif., Nov.
|
|
Friday, November 07, 2025 03:00 AM
Phase 1b data demonstrating favorable safety and tolerability profile and potent reductions in viral nucleic acids highlighted in late-breaking poster presentation – ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 11/11/25 | 32.11 | 33.11 | 31.02 | 33.13 | 65,222 |
| 10/11/25 | 31.70 | 32.36 | 31.50 | 32.07 | 71,741 |
| 07/11/25 | 30.89 | 31.77 | 30.65 | 31.20 | 126,424 |
| 06/11/25 | 32.33 | 32.435 | 31.115 | 31.29 | 78,652 |
| 05/11/25 | 31.85 | 32.31 | 31.65 | 32.03 | 83,456 |
| 04/11/25 | 30.80 | 32.28 | 30.80 | 31.43 | 129,496 |
| 03/11/25 | 31.06 | 31.60 | 30.00 | 31.17 | 91,850 |
| 31/10/25 | 30.32 | 31.80 | 30.30 | 31.05 | 70,081 |
| 30/10/25 | 30.6963 | 31.76 | 30.12 | 30.12 | 60,938 |
| 29/10/25 | 30.89 | 32.44 | 30.515 | 30.99 | 126,913 |
|
|
||||
|
|
||||
|
|